N. Scott Fine, Chief Executive Officer at Cyclo Therapeutics, Inc. (CYTH), bought 5,000 shares at $3.89 ($19K) on 2022-01-19, disclosed to the SEC on 2022-01-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CYTH | BUY | 2021-12-15 | $19K | — | Filing → |
| CYTH | BUY | 2021-12-02 | $25K | — | Filing → |
| CYTH | BUY | 2021-11-19 | $26K | — | Filing → |